CClinicalTrials.gg
CompletedNCT03317639Updated Aug 19, 2021

Improving In-hospital Stroke Service Utilisation in China

An interventional study of Behaviour Change Wheel model guided intervention in Thrombolytic Therapy, Acute Stroke and Door to Treatment Time, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2021-08-19.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
1,634
Allocation
Randomized
Sex
All
01

Study summary

A cluster randomised controlled trial will be conducted, using hospital as randomisation unit. Hospitals in Zhejiang Province, China, will be randomised into two arms (1:1): an intervention arm and a control arm. Hospitals in the intervention arm will receive a multi-components intervention based on the Behaviour Change Wheel model, whereas hospitals in the control arm will receive no intervention and maintain existing care. The randomisation will be conducted after one-year baseline data collection. The following baseline data will be used for randomisation match: hospital classification, beds in stroke centre, thrombolysis patient number, and percentage of patients receiving thrombolysis within 60 minutes of stroke onset. Hospitals with no stroke centre or with \<20 cases received thrombolysis per year will be excluded from the study. The primary outcome will be difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage (post-intervention).

02

Conditions studied

  • Thrombolytic Therapy
  • Acute Stroke
  • Door to Treatment Time
  • Quality Improvement

Browse trials for

03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • AIS patients receiving IVT within 4.5 hours

Exclusion criteria

Exclusion Criteria:

  • Patients who are not willing to attend this trial
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
1,634 participants (actual)

Study arms

  • Experimental
    an intervention arm

    Hospitals in the intervention arm will receive a multi-components intervention based on the Behaviour Change Wheel model

    Behavioral: Behaviour Change Wheel model guided intervention

  • No intervention
    a control arm

    hospitals in the control arm will receive no intervention and maintain existing care

Interventions

  • BehavioralBehaviour Change Wheel model guided intervention

    Interventions are developed on a psychological model, the Behaviour Change Wheel (BCW) .The fundamental of BCW consists of three essential elements: capability, motivation, and opportunity. Improving individual's capability, providing motivation, and increasing opportunities are goals of behaviour change intervention. To achieve the goals, 9 intervention components have been proposed in the BCW framework, and 6 components will be used in current study.

05

What researchers measure

Primary outcomes

  1. Difference in the percentage of patients who Door-to-Needle Time≤60min

    Difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage

    Time frame: Up to 24 hours

Secondary outcomes

  1. Door-to-needle time

    The time between hospital arrival and the initiation of IVT

    Time frame: Up to 24 hours

  2. Onset-to-needle time

    The time between the symptom onset and the initiation of IVT

    Time frame: Up to 24 hours

  3. modified Rankin Scale score at discharge

    modified Rankin Scale score at discharge, on which scores range from 0 (no neurologic deficit) to 6 (death)

    Time frame: Up to 3 month

  4. Symptomatic intracranial hemorrhage

    Intracranial hemorrhage at 24 hours associated with an increase of ≥4 points of NIHSS score from baseline, according to European Cooperative Acute Stroke Study (ECASS) II trial

    Time frame: At 24 hours

  5. Favorable neurological outcomes

    Score of 0 to 1 on the modified Rankin Scale, on which scores range from 0 (no neurologic deficit) to 6 (death)

    Time frame: At 90 days

  6. Death

    Death at discharge

    Time frame: Up to 3 month

06

Study locations

1 site
  • The second affiliated hospital of Zhejiang University
    Hangzhou, Zhejiang 310000, China
07

References and documents

Publications

  • Zhong W, Lin L, Gong X, Chen Z, Chen Y, Yan S, Zhou Y, Zhang X, Hu H, Tong L, Cheng C, Gu Q, Chen Y, Yu X, Huang Y, Yuan C, Lou M; MISSION investigators. Evaluation of a multicomponent intervention to shorten thrombolytic door-to-needle time in stroke patients in China (MISSION): A cluster-randomized controlled trial. PLoS Med. 2022 Jul 5;19(7):e1004034. doi: 10.1371/journal.pmed.1004034. eCollection 2022 Jul. PubMed 35788767 ↗
  • Wang J, Gong X, Zhong W, Zhou Y, Lou M. Novel Prehospital Triage Scale for Detecting Large Vessel Occlusion and Its Cause. J Am Heart Assoc. 2021 Sep 7;10(17):e021201. doi: 10.1161/JAHA.121.021201. Epub 2021 Aug 21. PubMed 34423654 ↗
08

Registry details

Key details

Study ID
NCT03317639
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators
Shaoxing Second Hospital, Haining People' s Hospital, Haiyan People' s Hospital, Huzhou No.1 People' s Hospital, Jiashan No.1 People' s Hospital, Ningbo Medical Center Lihuili Hospital, Tongxiang No.1 People' s Hospital, First Affiliated Hospital of Wenzhou Medical University, Yiwu Central Hospital, Yongkang No.1 People' s Hospital, Yuyao People's Hospital, Deqing People' s Hospital, Dongyang People' s Hospital, Jinhua People' s Hospital, Lishui People' s Hospital, Lin' an People' s Hospital, Longquan People' s Hospital, Qingtian People' s Hospital, Shaoxing Central Hospital, Wenzhou Central Hospital, Xiangshan No.1 People' s Hospital, The Central Hospital of Lishui City
Responsible party
Sponsor
First posted
Oct 23, 2017
Start date
Jan 1, 2018
Primary completion
Dec 31, 2019
Completion
Jun 30, 2020
Last update
Aug 19, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion